Indonesia
Waste handling is a critical matter in the
pharmaceutical industry which must be
considered, managed properly, and reported to
the competent authority, i.e. the Ministry of
Environment and the Environmental Service.
Waste which managed properly can protect the
environment, personnel, and the quality of
products produced by the pharmaceutical
industry. Therefore, the pharmaceutical
industry is obliged to handle and inspect waste
so that the waste produced by the
pharmaceutical industry meets the
environmental quality standards set by the
Ministry of Environment. There are several
regulations governing industrial waste handling
in Indonesia, especially pharmaceutical
industrial waste (Table 3). The techniques used
in order to handle the waste are similar to the
WHO guideline. In Indonesia, pharmaceutical
industry waste management is generally carried
out by autoclaving, incinerators, microwave
irradiation, chemical disinfection, sewer,
encapsulation, inertization and safe
burial/landfilling. For liquid waste, many
pharmaceutical industries use wastewater
treatment plant. The WHO guideline is quite
relevant and all methods are suitable to be
applied in Indonesia but still need improvement
on discipline and supervising, it also need to
develop new methods (18).
In the regulations, there are requirements that
must be met before the processed waste can be
disposed to the environment. Pharmaceutical
industries in Indonesia are required to report
the results of waste management inspections
to the authorities regularly.
In the Regulation of the State Minister for the
Environment of the Republic of Indonesia
Number 16 of 2012 Article 2 paragraph (2) it is
stated that the AMDAL, UKL-UPL and SPPL
are "Environmental Documents." Analisis
Dampak Lingkungan (AMDAL) or
Environmental Impact Analysis is a study of
the significant impacts of a business and / or
activity on the environment which is required
for the decision-making process regarding the
operation of a business and/or activity. Upaya
Pengelolaan Lingkungan Hidup dan Upaya
Pemantauan Lingkungan Hidup (UKL-UPL) or
Environmental Management Efforts and
Environmental Monitoring Efforts are
management and monitoring of businesses and
/ or activities that do not have a significant
impact on the environment required for the
decision-making process regarding the
operation of a business and/or activity. Surat
Pernyataan Pengelolaan Lingkungan (SPPL) or
Environmental Management Statement Letter,
is a form of commitment of business and/or
activity organizers to monitor and manage the
environment on the environmental impacts of
their business and/or activities outside of
businesses and/or activities that are mandatory
for AMDAL or UKL-PKL. Industries with
large and Significant Impacts must prepare
AMDAL, industries with Environmental
Impacts must prepare UKL-UPL (20, 21).
India
India is recognised as one of the most fast-
growing pharmaceutical industry globally.
India contributes 2.4% in terms of value and
10% in terms of quantity internationally. India
accounts for 20% of global exports in generics.
In 2016, the Indian pharmaceutical industry
exported USD 16.89 billion and is expected to
touch USD 40 billion by 2020 (22). Along with
the increased pharmaceutical industry in India,
so the amount of waste generated is bound to
increase. In India, the handling of
pharmaceutical waste generated has been
regulated since 1995 by Ministry of
Environment and Forests, Government of India
framed rules for managing Biomedical wastes.
The Biomedical Waste (Handling and
Management) Rules were published by India's
Ministry of Environment and Forests in 1998
(14, 15).
India’s Ministry of Environment and Forests
issued the Biomedical Waste (Handling and